0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Intensive Chemotherapy With Autologous Marrow Transplantation Is Effective Against Some Resistant Tumors

Beverly Merz
JAMA. 1987;257(2):151. doi:10.1001/jama.1987.03390020017004.
Text Size: A A A
Published online

ABSTRACT

CONVENTIONAL CANCER THERAPY can still be effective after tumors have become drug-resistant, according to some oncologists. They say that the secret is to treat patients with lethal doses of chemotherapy and to rescue them with autologous bone marrow transplantation.

For example, Emil Frei III, MD, director of the Dana Farber Cancer Institute in Boston, advises therapy with high doses of multiple agents. Frei told the recent Bristol-Myers Symposium on Cancer Research in Washington, DC, that his protocol involves the use of intensive chemotherapy employing combinations of alkylating agents, which in the last few years have been found to act synergistically and to trigger little cross-resistance.

At Dana Farber, following induction therapy with standard doses of cyclophosphamide and thio-TEPA, bone marrow is harvested and treated with monoclonal antibodies to eradicate tumor cells. Patients then undergo a short course of therapy with high doses of the two agents followed by marrow reinfusion.

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();